Back to libraryMuscle Growth

IGF-1 DES

Research profile · How we handle evidence

Des(1-3) IGF-1 (often written IGF-1 DES) is a truncated IGF-1 analog studied for altered receptor interactions.

Evidence Score

34/100

Preclinical signal

Category

Muscle Growth

Therapeutic area

Standard Dose

50-200mcg

Multiple times daily

Half-life

~1 hr

Plasma elimination

Route

SC / IM

Subcutaneous or Intramuscular

Safety Tier

3

Limited data

Overview

IGF-1 DES is a shortened form of IGF-1 where the first three amino acids are removed. In biochemical terms, that change can alter how the molecule interacts with IGF receptors and binding proteins, which is part of why researchers study this fragment. The practical side is that IGF-axis peptides can affect glucose/insulin-related pathways, so safety depends on dose, monitoring, and individual physiology. If you are researching these compounds, treat the topic as a high-stakes endocrine research area, not a casual supplement lane.

Mechanism of Action

IGF-1 DES is a shortened form of IGF-1 where the first three amino acids are removed. In biochemical terms, that change can alter how the molecule interacts with IGF receptors and binding proteins, which is part of why researchers study this fragment. The practical side is that IGF-axis peptides can affect glucose/insulin-related pathways, so safety depends on dose, monitoring, and individual physiology. If you are researching these compounds, treat the topic as a high-stakes endocrine research area, not a casual supplement lane.

Muscle RecoveryAthletic

pH & Mixing

9.7

Peptides reconstituted at very different pH levels can destabilize when combined in the same syringe, which lowers how much of the peptide your body actually absorbs. If you're unsure whether two peptides are close enough in pH, reconstitute and inject them separately.

A dedicated compatibility check between two specific peptides is coming to the Compare tool. This section covers this peptide's pH only.

Benefits

  • Enhanced muscle growth
  • Faster action than IGF-1
  • Localized effects
  • Increased protein synthesis

Side Effects

  • Hypoglycemia
  • Injection site reactions
  • Potential organ growth

Contraindications

  • Cancer
  • Pregnancy
  • Minors

Structure & Sequence

Verified structure

IGF-1 DES

Illustration uses the catalog amino acid sequence because no exact external registry match was confirmed.

Sequence-backed
C319H501N91O96S77,371.5 Da67 residues
Amino Acid Sequence
TLCGAELVDALQFVCGDRGFYFNKPTGYGSSSRRAPQTGIVDECCFRSCDLRRLEMYCAPLKAAKSA
Molecular Weight
7,371.5 Da
Chemical Formula
C319H501N91O96S7
CAS Number
N/A
Reconstituted pH
9.7

Stack & Route Context

Stacks with

  • HGH
  • Testosterone

Administration

Subcutaneous or Intramuscular

Research Status

Research chemical

Approval Status

Preclinical

Sports Legal

Restricted

References

No references listed.

This profile summarizes research literature for education only. It is not medical advice, and it does not diagnose, treat, or recommend a dose. Consult a qualified professional before changing a protocol.

Research-driven insights.Evidence-based decisions.